common.study.topics.clinical

Daily vs Intermittent Iron Therapy in Pregnancy

common.study.values.description

Daily vs Intermittent Iron Therapy in Pregnancy

This is a randomized non inferiority trial to evaluate the response to iron therapy in the standard daily vs. intermittent (three-four times a week on nonconsecutive days) groups by using hematological markers (hemoglobin, hematocrit, transferrin, hepcidin, ferritin, human soluble transferrin receptor). The secondary outcome is to evaluate gastrointestinal discomfort and adherence to therapy between two treatment groups.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Dietary Supplement - Ferrous Sulfate

Patients would be randomized to either taking ferrous sulfate daily or every other day (on non consecutive days).

participant.views.study.view.additional

participant.views.study.view.scientific-title

Daily vs. Intermittent Iron Therapy in Iron Deficient Pregnant Patients: A Randomized Noninferiority Trial

common.study.values.clinical-trial-id

NCT03706638

participant.views.study.view.id

bW6qJa